LB-S&T-21 A PHASE 2 STUDY OF VESIMUNE®, INTRAVESICAL IMIQUIMOD, FOR THE TREATMENT OF CARCINOMA IN SITU BLADDER CANCER

Overview

authors

Donin, Nicholas
Chamie, Karim
Reddy, Madhu
Kivlin, Dana
Holldack, Johanna
Pozzi, Raffaella
Hakim, Gil
Holden, Stuart
Karsh, Lawrence, MD, FACS, CPI
Lamm, Donald
Belkoff, Laurence
Belldegrun, Arie
Shore, Neal

Publication Date

2016

webpage

http://dx.doi.org/10.1016/j.juro.2016.03.102

published in

JOURNAL OF UROLOGY Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.